- Home
- COCO vs SPRY Comparison
COCO vs SPRY Comparison
Compare COCO & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCO
- SPRY
- Stock Information
- Founded
- COCO 2004
- SPRY 2015
- Country
- COCO United States
- SPRY United States
- Employees
- COCO N/A
- SPRY N/A
- Industry
- COCO Beverages (Production/Distribution)
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- COCO Consumer Staples
- SPRY Health Care
- Exchange
- COCO Nasdaq
- SPRY Nasdaq
- Market Cap
- COCO 1.7B
- SPRY 1.4B
- IPO Year
- COCO 2021
- SPRY N/A
- Fundamental
- Price
- COCO $36.63
- SPRY $13.38
- Analyst Decision
- COCO Buy
- SPRY Strong Buy
- Analyst Count
- COCO 7
- SPRY 4
- Target Price
- COCO $31.00
- SPRY $24.00
- AVG Volume (30 Days)
- COCO 686.0K
- SPRY 1.3M
- Earning Date
- COCO 10-30-2024
- SPRY 11-13-2024
- Dividend Yield
- COCO N/A
- SPRY N/A
- EPS Growth
- COCO 56.82
- SPRY N/A
- EPS
- COCO 1.00
- SPRY N/A
- Revenue
- COCO $494,864,000.00
- SPRY $2,568,000.00
- Revenue This Year
- COCO $5.30
- SPRY $21,686.67
- Revenue Next Year
- COCO $11.62
- SPRY $956.61
- P/E Ratio
- COCO $36.73
- SPRY N/A
- Revenue Growth
- COCO 3.21
- SPRY 8460.00
- 52 Week Low
- COCO $19.41
- SPRY $4.65
- 52 Week High
- COCO $37.04
- SPRY $18.51
- Technical
- Relative Strength Index (RSI)
- COCO 73.29
- SPRY 38.12
- Support Level
- COCO $33.49
- SPRY $13.36
- Resistance Level
- COCO $36.41
- SPRY $18.51
- Average True Range (ATR)
- COCO 1.39
- SPRY 1.18
- MACD
- COCO 0.09
- SPRY -0.33
- Stochastic Oscillator
- COCO 91.99
- SPRY 6.73
About COCO The Vita Coco Company Inc.
The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. Geographical presence of the company is in United States, Canada, Europe, Middle East, Africa, and the Asia Pacific regions.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.